INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2023-09-28 ms5000000116399737 来自湖北省

偏重的研究方向：生物信息学;肿瘤;癌症
经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受

49 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2023-06-16 ms7000001030262158 来自陕西省

pending review14天了。。也不知道是好消息还是坏消息。。

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2023-05-23 ms6000000943723480 来自山西省

pending review 7天了，催稿也不说怎么回事，一直吊着，难受.......

30 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2023-06-27 ms2000001012517690 来自江苏省

投稿命中率:50.0
偏重的研究方向：膳食纤维;2型糖尿病
经验分享：6.22投 6.27被拒没写原因模板拒

34 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2023-08-27 雪儿9496 来自辽宁省

请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2022-10-14 148609fcm78暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：机制;肿瘤;信号通路
经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗

130 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2023-06-15 1487e742m42(暂无昵称) 来自内蒙古

偏重的研究方向：OvCa;机制
经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。

43 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2023-04-29 ms8000000030832967 来自重庆

偏重的研究方向：干细胞
经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂

64 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2023-02-28 ms6000000442592867 来自山东省

这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下

55 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160221, encodeId=45e0216022184, content=偏重的研究方向：生物信息学;肿瘤;癌症 经验分享：肿瘤，生信加体外细胞实验验证，投稿后次日送审，一个月外审，小修，2日修回，3日后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46278239970, createdName=ms5000000116399737, createdTime=Thu Sep 28 18:21:42 CST 2023, time=2023-09-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143223, encodeId=4728214322335, content=pending review14天了。。也不知道是好消息还是坏消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b116483204, createdName=ms7000001030262158, createdTime=Fri Jun 16 22:02:30 CST 2023, time=2023-06-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2138527, encodeId=6adf213852e60, content=pending review 7天了，催稿也不说怎么回事，一直吊着，难受......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec798606174, createdName=ms6000000943723480, createdTime=Tue May 23 09:03:35 CST 2023, time=2023-05-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145080, encodeId=3a0f214508092, content=投稿命中率:50.0 偏重的研究方向：膳食纤维;2型糖尿病 经验分享：6.22投 6.27被拒没写原因模板拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bf58667390, createdName=ms2000001012517690, createdTime=Tue Jun 27 20:26:48 CST 2023, time=2023-06-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2154780, encodeId=f23a2154e80eb, content=请问大神们，这个杂志投稿的时候要选择research topics，special issue 和topic和collection 有什么区别嘛，感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq3FnLd4wiaa1qPKblG4cBH2ic1gbqQUMAahTJlkwY8dqQBIGfaQ6ibNKZqOVG3ZZsia3bJdUdrd9mPKA/132, createdBy=2fe15355888, createdName=雪儿9496, createdTime=Sun Aug 27 10:56:25 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2093704, encodeId=92392093e04de, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：机制;肿瘤;信号通路 经验分享：看到大家说国内医院单位投的都被拒了，那我投的综述也会面临同样的原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=552d5290340, createdName=148609fcm78暂无昵称, createdTime=Fri Oct 14 00:28:07 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142893, encodeId=d47921428934e, content=偏重的研究方向：OvCa;机制 经验分享：2023-06-10 投稿，5天了还是Pending review，是不是凉了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Thu Jun 15 09:25:20 CST 2023, time=2023-06-15, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2129153, encodeId=69ea2129153e9, content=偏重的研究方向：干细胞 经验分享：感觉审稿人和编辑很严谨负责，三个审稿人，审稿一个月，其中两个提出来很多建议，要求补实验，另一个审稿人不友好，提出的问题真的是很刁钻。给的是大修，补了一个月实验返回去后，两个审稿人比较满意，还有一个审稿人对个别问题不满意，又进行了两轮回复。审稿人同意了，编辑决定等了差不多两周，然后编辑提出一些很细节的问题，以及统计相关的问题，回答了三轮，终于接收了。个人感觉效率还可以，着急毕业可以试试。自我感觉自己文章并不水，投稿并不是想象中那么easy，编辑很严谨负责😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Sat Apr 29 02:15:02 CST 2023, time=2023-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2116962, encodeId=25ca21169624b, content=这个杂志真的是作者单位是中国医院就秒拒吗，，，最近准备投一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65706579694, createdName=ms6000000442592867, createdTime=Tue Feb 28 22:15:27 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2146459, encodeId=a1ce2146459fe, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：6.29投的，快一周了，怎么海没有消息呢 各位大神是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad68445869, createdName=ms6000000171116205, createdTime=Wed Jul 05 15:50:55 CST 2023, time=2023-07-05, status=1, ipAttribution=广东省)]

2023-07-05 ms6000000171116205 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：炎症
经验分享：6.29投的，快一周了，怎么海没有消息呢
各位大神是什么情况呀

38 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务